Publications

As a science-first, founder-led dermaceutical platform, our peer-reviewed publications reflect the scientific depth and translational rigor behind CuralysMD™.

Rapid Improvement of Pediatric Atopic Dermatitis with a Standardized Isosorbide Diester Moisturizer Used Alongside NB- UVB Phototherapy: A Case Report

S Ndubisi, P Lio
J Integrative Dermatology, 2026, published online
Read More

Impact of Isosorbide Diesters from Coconut and Sunflower Fatty Acids on Pediatric Atopic Dermatitis and the Skin Microbiome: A Randomized Double-Blind Vehicle-Controlled Trial

Z Khan, AS. Dulai, A O’Neill, M Min, J Lee, C Dion, N Afzal, RK Chaudhuri, A Lee & RK Sivamani
J Clinical Medicine, 2026, 15, 829
Read More

Isosorbide Diesters: Mechanistic Insights and Therapeutic Applications in Skin and Neuroinflammatory Disorders

RK Chaudhuri & TA Meyer
International J Molecular Science, 2025, 26, 11855.
Read More

Prospective randomized double-blind vehicle-controlled study of isosorbide diesters based moisturizer on skin health of atopic dermatitis patients

D Nadora, W Burney, RK Chaudhuri, A Galati, CJ Chambers & RK Sivamani
Dermatitis, 2024, 35, S62-S69
Read More

Isosorbide fatty acid diesters have synergistic anti-inflammatory effects in cytokine-induced tissue culture models of atopic dermatitis

WR Swindell, K Bojanowski & RK Chaudhuri
International J Molecular Science, 2022, 23, 14307
Read More

Isosorbide Di-(linoleate/oleate) stimulates pro-differentiation gene expression to restore the epidermal barrier and improve skin hydration

K Bojanowski, WR Swindell, S Cantor & RK Chaudhuri
J Investigative Dermatology, 2021, 141, 1416-1427
Read More

Improvements of hydration and epidermal barrier function in human skin by novel compound isosorbide dicaprylate

RK Chaudhuri & K Bojanowski
International J Cosmetic Science, 2017, 39, 518-526
Read More

Clinical Insights. Real Solutions.

Engage with our team to explore the science behind CuralysMD™ and how our platform redefines eczema care through clinically validated barrier-first dermatology.